Ignyte Design

Ignyte Design company information, Employees & Contact Information

Explore related pages

Ignyte Design email format Ignyte Design management contacts

Related company profiles:

IGNYTE Design was created to transform the engineering consultant experience. We strive to create a connected and humanized experience. With the result being high performance building systems.

Company Details

Employees
21
Founded
-
Address
Grand Rapids, Michigan, Us
Industry
Architecture And Planning
NAICS
Architectural Services
Website
https://www.ignyte.design
Keywords
Holland.
HQ
Grand Rapids, Michigan
Competitors
TowerPinkster, MATHISON | MATHISON ARCHITECTS, ROSSETTI, Progressive Companies, GMB, Pure Architects, Integrated Architecture, Paradigm Design, InForm Architecture, LLC, C2AE.
Looking for a particular Ignyte Design employee's phone or email?

Ignyte Design Questions

News

Scientists Behind Trial of Replimune’s Tumor Destroyer Protest FDA’s Rejection - BioSpace

Scientists Behind Trial of Replimune’s Tumor Destroyer Protest FDA’s Rejection BioSpace

FDA rejects Replimune’s oncolytic virus | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

FDA rejects Replimune’s oncolytic virus | ApexOnco - Clinical Trials news and analysis Oncology Pipeline

FDA Crackdown on Trial Design: What July’s CRLs to Replimune and Capricor Mean for Sponsors - Applied Clinical Trials

FDA Crackdown on Trial Design: What July’s CRLs to Replimune and Capricor Mean for Sponsors Applied Clinical Trials

FDA Approval Path Remains Unclear for RP1 in Melanoma - Targeted Oncology

FDA Approval Path Remains Unclear for RP1 in Melanoma Targeted Oncology

FDA Rejects Oncolytic Virus Combination for Advanced Melanoma - Oncology News Central

FDA Rejects Oncolytic Virus Combination for Advanced Melanoma Oncology News Central

IGNYTE Trial Investigators Press FDA to Reconsider Replimune CRL Amid Promising Melanoma Data, Leadership Shakeup - Pharmaceutical Executive

IGNYTE Trial Investigators Press FDA to Reconsider Replimune CRL Amid Promising Melanoma Data, Leadership Shakeup Pharmaceutical Executive

RP1 Yields Responses in Deep/Visceral Lesions and Across Injected/Non-Injected Lesions in Advanced PD-1–Refractory Melanoma - OncLive

RP1 Yields Responses in Deep/Visceral Lesions and Across Injected/Non-Injected Lesions in Advanced PD-1–Refractory Melanoma OncLive

Replimune (REPL) Faces Securities Class Action Following - GlobeNewswire

Replimune (REPL) Faces Securities Class Action Following GlobeNewswire

Ignite Visibility Acquires Outliant, a Leading Web Development Agency - PRWeb

Ignite Visibility Acquires Outliant, a Leading Web Development Agency PRWeb

FDA Issues Complete Response Letter to Replimune for RP1 Combination Therapy in Advanced Melanoma - Applied Clinical Trials

FDA Issues Complete Response Letter to Replimune for RP1 Combination Therapy in Advanced Melanoma Applied Clinical Trials

FDA Issues CRL for RP1 in Advanced Melanoma - Targeted Oncology

FDA Issues CRL for RP1 in Advanced Melanoma Targeted Oncology

Replimune (REPL) Faces Investor Lawsuit After FDA Blocks Cancer Drug Approval - Hagens Berman - GlobeNewswire

Replimune (REPL) Faces Investor Lawsuit After FDA Blocks Cancer Drug Approval - Hagens Berman GlobeNewswire

FDA Issues CRL for RP1 and Nivolumab in Melanoma - Dermatology Times

FDA Issues CRL for RP1 and Nivolumab in Melanoma Dermatology Times

Replimune Viral-Based Therapy for Melanoma Rejected By FDA - Inside Precision Medicine

Replimune Viral-Based Therapy for Melanoma Rejected By FDA Inside Precision Medicine

Ignyte and Binance Join Forces to Drive Blockchain Innovation Across MENA - TechAfrica News

Ignyte and Binance Join Forces to Drive Blockchain Innovation Across MENA TechAfrica News

Replimune's RP1 for Advanced Melanoma Has Received BLA Acceptance and Priority Review - Oncodaily

Replimune's RP1 for Advanced Melanoma Has Received BLA Acceptance and Priority Review Oncodaily

Replimune's shares crater as FDA rejects melanoma drug - Fierce Biotech

Replimune's shares crater as FDA rejects melanoma drug Fierce Biotech

Replimune (REPL) Faces Securities Class Action Following - GlobeNewswire

Replimune (REPL) Faces Securities Class Action Following GlobeNewswire

Ignyte Helmets launches 36 ECE 22.06 certified models in European market at EICMA 2024 - ET Auto

Ignyte Helmets launches 36 ECE 22.06 certified models in European market at EICMA 2024 ET Auto

FDA Denies Approval for Replimune's Advanced Melanoma Treatment: What's Behind the Rejection - Stock Titan

FDA Denies Approval for Replimune's Advanced Melanoma Treatment: What's Behind the Rejection Stock Titan

IGNYTE debuts at EICMA 2024 with over 36 ECE 22.06/DOT certified models - Autocar Professional

IGNYTE debuts at EICMA 2024 with over 36 ECE 22.06/DOT certified models Autocar Professional

Seasoned Life Sciences Team Launches Ignyte Bio To Speed Therapeutics Discovery - Business Wire

Seasoned Life Sciences Team Launches Ignyte Bio To Speed Therapeutics Discovery Business Wire

EICMA 2024: Indian Helmet Brand IGNYTE Showcases Multiple Products at Word's Biggest Motor show - News18

EICMA 2024: Indian Helmet Brand IGNYTE Showcases Multiple Products at Word's Biggest Motor show News18

IGNYTE Helmets launches vintage-styled IGN-58 - financialexpress.com

IGNYTE Helmets launches vintage-styled IGN-58 financialexpress.com

Steelbird to unveil IGNYTE range at EICMA 2024 - financialexpress.com

Steelbird to unveil IGNYTE range at EICMA 2024 financialexpress.com

ICC Launches Global Hackathon to Elevate Women in Sports Technology - Cricket World Cup

ICC Launches Global Hackathon to Elevate Women in Sports Technology Cricket World Cup

Steelbird to showcase India-manufactured ECE 22.06 and DOT-certified helmets at EICMA 2024 - ET Manufacturing

Steelbird to showcase India-manufactured ECE 22.06 and DOT-certified helmets at EICMA 2024 ET Manufacturing

Gear Review | Ignyte IGN 8 Helmet - TopGear India

Gear Review | Ignyte IGN 8 Helmet TopGear India

Ignyte Helmets launches IGN-58 open-face helmets at Rs 2,999 - motownindia.com

Ignyte Helmets launches IGN-58 open-face helmets at Rs 2,999 motownindia.com

Is Ignyte the Panacea for Dubai’s Entrepreneurs? - SME10X

Is Ignyte the Panacea for Dubai’s Entrepreneurs? SME10X

Steelbird Introduces Ignyte Winter Riding Gear In India - Car and Bike

Steelbird Introduces Ignyte Winter Riding Gear In India Car and Bike

Steelbird Introduce Ignyte Motorcycle Jackets - bikeindia.in

Steelbird Introduce Ignyte Motorcycle Jackets bikeindia.in

Steelbird Introduces Ignyte Range of Rain Gear - BikeAdvice

Steelbird Introduces Ignyte Range of Rain Gear BikeAdvice

Steelbird launches IGNYTE series riding gear in India - overdrive.in

Steelbird launches IGNYTE series riding gear in India overdrive.in

Companies like Ignyte Design

GMB logo - Similar company to Ignyte Design

Gmb

287
TowerPinkster logo - Similar company to Ignyte Design

Towerpinkster

245
C2AE logo - Similar company to Ignyte Design

C2Ae

126
ROSSETTI logo - Similar company to Ignyte Design

Rossetti

200
Progressive Companies logo - Similar company to Ignyte Design

Progressive Companies

406
Integrated Architecture logo - Similar company to Ignyte Design

Integrated Architecture

57
MATHISON | MATHISON ARCHITECTS logo - Similar company to Ignyte Design

Mathison | Mathison ...

21
Pure Architects logo - Similar company to Ignyte Design

Pure Architects

27
InForm Architecture, LLC logo - Similar company to Ignyte Design

Inform Architecture,...

12
Paradigm Design logo - Similar company to Ignyte Design

Paradigm Design

94

Top Ignyte Design Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant